Tongjitang Chinese Medicines Company to Announce First Quarter 2009 Financial Results on June 3, 2009

SHENZHEN, China--(BUSINESS WIRE)--May 27, 2009 - Tongjitang Chinese Medicines Company (NYSE: TCM) (“Tongjitang” or the “Company”), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine (“TCM”) in China, today announced that it plans to announce its first quarter 2009 financial results before the market opens on Wednesday, June 3, 2009.

Tongjitang's management team will hold a conference call on June 3, 2009, at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing/Hong Kong time) following the announcement. Listeners may access the call by dialing the following numbers:

United States toll free: 1-888-378-0337

 

Hong Kong toll free: 800-968-103
Northern China toll free: 10 800 712 0046
Southern China toll free: 10 800 120 0046
International: 1-719-325-2106

 

 
Listeners may access the replay through June 10, 2009, by dialing the following numbers:
United States toll free: 1-888-203-1112
International: 1-719-457-0820
Password: 8847791
An audio webcast of the call will also be available through the Company's website at www.tongjitang.com.

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante and Anhui Jingfang, is a vertically integrated and profitable specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang's principal executive offices are located in Shenzhen, China.

Tongjitang's flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 36 other modernized traditional Chinese medicine products and 37 western medicines. Please visit www.tongjitang.com for more information.

Contact: ICR, Inc.
Ashley M. Ammon or Christine Duan
203-682-8200 (Investor Relations)

Posted: May 2009

View comments

Hide
(web5)